Research Topic

Advances in Engineered T Cells

  • Submission closed.

About this Research Topic

Pediatric cancers in need of new and effective interventions include relapsed or refractory brain tumors like glioblastoma and DIPG; sarcomas like osteosarcoma and rhabdomyosarcoma; and neuroblastoma. Adoptive Immunotherapy with engineered T cells for pediatric cancers has been a major focus of laboratory ...

Pediatric cancers in need of new and effective interventions include relapsed or refractory brain tumors like glioblastoma and DIPG; sarcomas like osteosarcoma and rhabdomyosarcoma; and neuroblastoma. Adoptive Immunotherapy with engineered T cells for pediatric cancers has been a major focus of laboratory research and is just now being clinically evaluated. The most effective lymphocyte effector populations are being defined with increasing specificity in order to meet the challenges that immunotherapy of solid tumors present, in contrast to the current success seen with pre-B ALL. This Research Topic will focus of novel chimeric antigen receptor (CAR) formats, new genetic payloads that enhance T cell anti-tumor activity, and the creation or selection of lymphocyte populations that more effectively penetrate and resist the immune-inhibitory tumor microenvironment.


Keywords: CAR-T, Leukemia, Pediatric Cancer, Glioblastoma, Sarcoma


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

Submission closed.

Participating Journals

Loading..

Topic Editors

Loading..

Submission Deadlines

Submission closed.

Participating Journals

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top
);